FU Ran, WANG Xiaonan, LI Yajing, DING Congyang, MENG Lu, DONG Zhanjun. Advances in Transporter-mediated Drug Interactions with Methotrexate[J]. Chinese Journal of Modern Applied Pharmacy, 2020, 37(21): 2684-2688. DOI: 10.13748/j.cnki.issn1007-7693.2020.21.022
    Citation: FU Ran, WANG Xiaonan, LI Yajing, DING Congyang, MENG Lu, DONG Zhanjun. Advances in Transporter-mediated Drug Interactions with Methotrexate[J]. Chinese Journal of Modern Applied Pharmacy, 2020, 37(21): 2684-2688. DOI: 10.13748/j.cnki.issn1007-7693.2020.21.022

    Advances in Transporter-mediated Drug Interactions with Methotrexate

    • Methotrexate is an anti-folate antitumor drug, which is often used to treat cancer, rheumatoid arthritis and psoriasis. Methotrexate has a significant therapeutic effect, but its treatment window is narrow. Various transporters are involved in the disposal of methotrexate in vivo. When methotrexate is used in combination with other drugs, drug interactions based on transporters are likely to occur, leading to side effects or changes in efficacy. This article summarized the transport-mediated drug-drug innteractions of methotrexate to provide references information for rational administration of medication in clinic.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return